Antibody Drug Conjugate Market to Reach USD 51.10 Billion by 2035 at 15.01% CAGR
Antibody Drug Conjugate Market Overview The Antibody Drug Conjugate Market is expanding rapidly as oncology moves toward targeted therapies that can deliver potent cytotoxic payloads directly to cancer cells. Antibody-drug conjugates (ADCs) combine a tumor-targeting antibody, a chemical linker, and … Read more